Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"
1 other identifier
interventional
973
1 country
1
Brief Summary
Lung cancer is the most frequently dianosed cancer worldwide. To date, no screening method has been able to establish itself as routinely recommended by the guidelines. In this prospective study with 1:1 randomized questioning using an Internet tool, physicians will be asked in 2 phases (before and after intervention with a fact box) about their assessment of the benefits and risks of lung cancer screening by thoracic computed tomography and about a potential intention to change referral behavior. Randomly assigned, half of the participants will receive the same information in addition to the fact box graphically presented as a Cates plot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started May 2021
Shorter than P25 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 29, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedMarch 18, 2024
March 1, 2024
6 months
March 24, 2021
March 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CT-Screening
Proportion of physicians CT-Screening
through study completion, an average of 1 year
Study Arms (2)
Cate Plots
OTHERafter being asked about current referral practices and assessment of benefits and risks of lung cancer screening, all respondents will receive the Fact box after which they will be randomized into two equal groups. The first group (Arm 1) receives a Cates plot and then another survey about assessment of benefits and risks of lung cancer screening and potential change in referral behavior.
Fact box only
OTHERafter being asked about current referral practices and assessment of benefits and risks of lung cancer screening, all respondents will receive the Fact box after which they will be randomized into two equal groups. The second group (Arm 2) receives then a survey about assessment of benefits and risks of lung cancer screening and potential change in referral behavior
Interventions
All physicians surveyed receive a fact box with numerical information on the benefits and harms of chest CT as a screening method. In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Eligibility Criteria
You may qualify if:
- Members of the Austrian Society of Pneumology (ÖGP) with a completed pulmonary subject and members of the Austrian Radiological Society (ÖRG), Society for Medical Radiology and Nuclear Medicine with a completed subject.
You may not qualify if:
- Non members of the Austrian Society of Pneumology (ÖGP)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie
Vienna, 1160, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg-Christian Funk, MD
2nd Medical Department with Pneumology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2021
First Posted
March 29, 2021
Study Start
May 1, 2021
Primary Completion
October 30, 2021
Study Completion
October 30, 2021
Last Updated
March 18, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share